Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
COME SEE OUR BONA FIDE NOT AVAILABLE TESTS. YOU CAN’T GET ONE ANYWHERE IN THE WORLD, BECAUSE THEY ARE BONA FIDE, NOT AVAILABLE.
WE ARE THE NOT AVAILABLE TEST COMPANY!
WE ARE THE FIRST COMPANY IN THE WORLD THAT MAKES A COVID-19 TEST THAT IS NOT AVAILABLE. COME AND TRY TO BUY ONE, AND WE WILL PROVE THAT IT’S NOT AVAILABLE.
OUR TEST IS THE FASTEST AND NOT AVAILABLE. IN THE BLINK OF AN EYE AND RECORD BREAKING TIME WE CAN TELL ANYONE THAT OUR TEST IS “NOT AVAILABLE;” YES WE CAN!
MAKE A “NOT AVAILABLE” SWEAT AND TEAR TEST TOO.
“NOT AVAILABLE” TAKES PRECEDENCE OVER ALL ELSE.
IF DONIGER CAN PRESENT THE GV-SPIT AND BLOOD TESTS TO THE ATTENTION OF THE PRESIDENT, AND THE PRESIDENT SAY’S, “WE NOW HAVE A TRUE REVOLUTIONARY 10.5 SECOND COVID-19 TEST THAT WILL DECREASE WAIT TIMES AND DRAMATICALLY REDUCE OR ELIMINATE THE BACKLOGS AND PREVENT BACKLOGS FROM OCCURRING,” AND FAUCI STEPS UP AND CONCURS, GAME OVER. AND THEN SOMEONE WILL SAY, “BUT LOOK, IT’S NOT AVAILABLE.”
NOT AVAILABLE; SEE: https://pharmatechsolutions.co/genviro.html
AMAZING TEST THAT’S NOT AVAILABLE; RIGHT BERMAN?
CONGRESS WILL LOBBY FOR NOT AVAILABLE GENVIRO? BRILLIANT!!!!!
THE NOT AVAILABLE GENVIRO TEST CAN HELP HUMANITY. GREAT JOB, NOT AVAILABLE.
ALL THE SEC HAS TO SAY: NOT AVAILABLE. HERE’S THE PROOF: https://pharmatechsolutions.co/genviro.html
HELLO FBI. GENVIRO IS “NOT AVAILABLE.” CHECK THIS WEBSITE https://pharmatechsolutions.co/genviro.html
SEC IS RIGHT. GENVIRO WAS/IS NOT AVAILABLE.
GENVIRO IS A NOT AVAILABLE COVID-19 TEST.https://pharmatechsolutions.co/genviro.html
SAYS GENVIRO, NOT AVAILABLE ON THE WEBSITE:https://pharmatechsolutions.co/genviro.html
GENVIRO IS PROVEN TO BE NOT AVAILABLE.
GENVIRO, NOT AVAILABLE, DOES NOT BENEFIT HUMANITY.
GenViro is NOT AVAILABLE AND CURRENTLY USELESS.
This Genviro is not making any difference in testing efficiency, because it’s not available.
Russia to approve COVID-19 vaccine by mid-August. https://www.cnn.com/2020/07/28/europe/russia-coronavirus-vaccine-approval-intl/index.html
GENVIRO IS THE ONLY DUAL MODALITY, SALIVA, BLOOD, 10.5 SECOND COVID-19 TEST IN THE WORLD. GENVIRO IS EXCLUSIVE TO DECN.
STRONG CHART - - .28 SUPPORT:
http://www.stockta.com/cgi-bin/analysis.pl?symb=DECN&cobrand=&mode=stock
FROM 7/10/20 PR:
GENVIRO IS A DUAL BLOOD AND SALIVA TEST, ALL IN ONE.
THE SAME METER AND STRIPS WILL BE USED INTERCHANGEABLY FOR THE FINGER BLOOD DROP AND/OR THE SALIVA. THE GENVIRO KIT IS DESIGNED TO BE COMPATIBLE FOR BLOOD OR SALIVA SAMPLES. EITHER SAMPLE CAN BE TESTED ON THE SAME DEVICE AND THE STRIPS DON’T NEED ANY MODIFICATIONS BETWEEN BLOOD OR SALIVA. IT WORKS FOR BOTH. Read the press release excerpt, below. This is going to be huge.
“Since both the original finger stick and new saliva methods use the GenViro! Swift test strips and reader device, the addition of the saliva test option should have no impact on the current test strip design or final development and testing schedule. Both methods are expected to provide the accuracy, immediacy and affordability needed to help control the spread of the virus.
"Offering a second, independent, rapid, safe and reliable....”
https://www.accesswire.com/596976/DECN-to-add-GenViro-Saliva-Covid-19-Swift-Kit-105-for-Professional-and-Home-Use-Testing-Providing-an-Alternative-Modality-to-its-Finger-Stick-Methodology
“quick, cheap test why don't we have?”https://www.usatoday.com/story/news/health/2020/07/26/covid-testing-cheap-quick-home-rapid-test-needed-experts-say/5491744002/
US could see 'further suffering and further death' if coronavirus isn't controlled, Fauci says
By Christina Maxouris, CNN
Updated 8:46 AM EDT, Tue July 28, 2020
https://www.cnn.com/2020/07/28/health/us-coronavirus-tuesday/index.html
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128549/
Coronaviruses were identified in the mid-1960s and known to infect humans and other animals, including birds and mammals. Epithelial cells in the respiratory and gastrointestinal tract are the primary target cells. Due to these characters, viral shedding occurs via these systems and transmission can occur through different routes, i.e., fomites, airborne or fecal-oral. To date, seven coronaviruses have been shown to infect humans. Common human coronaviruses Betacoronavirus HCoV-OC43 and HCoV-HKU1, as well as Alphacoronavirus HCoV-229E, cause common colds and severe lower respiratory tract infections in infants and elderly, while Alphacoronavirus HCoV-NL63 is found to be a significant cause of (pseudo) croup and bronchiolitis in children [1].
Emerging viruses that spread to humans from an animal host are proven to be some of the deadliest diseases known [2,3]. COVID-19 is thought to be transmitted from the animals, though it has not yet been clear exactly from which animal, however the animals have been the sources of transmission as described in Fig. 1 . The recent finding shows that SARS-CoV-2 is 96% identical to a bat coronavirus [2]. We aimed to discuss the zoonotic transmission of SARS-CoV-2 to humans.
New zoonotic coronaviruses have emerged and caused outbreaks in humans; SARS-CoV (2002, Betacoronavirus, subgenus Sarbecovirus), and MERS-CoV (2012, Betacoronavirus, subgenus Merbecovirus). In late 2019, a novel coronavirus related to a cluster of pneumonia cases in Wuhan, China (2019-nCoV), was identified. After that the disease designed as COVID-19. The SARS-CoV-2 is closely related to SARS-CoV and genetically clusters within Betacoronavirus subgenus Sarbecovirus [1].
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128549/
Read link: Knowledge of the processes underlying viral mutation rates has implications for understanding and managing drug resistance, immune escape, vaccination, pathogenesis, and the emergence of new diseases.
A similar scenario can be depicted for antiviral immunity. Viruses showing high mutation rates tend to evade immunity more efficiently.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075021/
READ LINK: Viral mutations will not interfere with the impedance fingerprints and yield identical results. Mutations do not cause conflicting and contradictory impedance results, because the mutations are at the genetic nucleotide sequence level and very small.
“...have two key potential advantages: the ability to continuously monitor the environment, and to detect unspecified viruses and mutants, since biological information on genomes or receptors is not required.
The data clearly showed that the virus concentration can be quantified by the impedance value. Furthermore, the three virus types could be distinguished by plotting the phase at 100 kHz against the phase of the peak value of the imaginary component of the impedance for each virus type.
The results nevertheless show that the proposed nonlinear impedance spectroscopy method may achieve a sensitivity comparable to that of PCR and immunodetection systems.
https://www.frontiersin.org/articles/10.3389/fmicb.2015.00940/full
Coronaviruses were identified in the mid-1960s and known to infect humans and other animals, including birds and mammals. Epithelial cells in the respiratory and gastrointestinal tract are the primary target cells. Due to these characters, viral shedding occurs via these systems and transmission can occur through different routes, i.e., fomites, airborne or fecal-oral. To date, seven coronaviruses have been shown to infect humans. Common human coronaviruses Betacoronavirus HCoV-OC43 and HCoV-HKU1, as well as Alphacoronavirus HCoV-229E, cause common colds and severe lower respiratory tract infections in infants and elderly, while Alphacoronavirus HCoV-NL63 is found to be a significant cause of (pseudo) croup and bronchiolitis in children [1].
Emerging viruses that spread to humans from an animal host are proven to be some of the deadliest diseases known [2,3]. COVID-19 is thought to be transmitted from the animals, though it has not yet been clear exactly from which animal, however the animals have been the sources of transmission as described in Fig. 1 . The recent finding shows that SARS-CoV-2 is 96% identical to a bat coronavirus [2]. We aimed to discuss the zoonotic transmission of SARS-CoV-2 to humans.
New zoonotic coronaviruses have emerged and caused outbreaks in humans; SARS-CoV (2002, Betacoronavirus, subgenus Sarbecovirus), and MERS-CoV (2012, Betacoronavirus, subgenus Merbecovirus). In late 2019, a novel coronavirus related to a cluster of pneumonia cases in Wuhan, China (2019-nCoV), was identified. After that the disease designed as COVID-19. The SARS-CoV-2 is closely related to SARS-CoV and genetically clusters within Betacoronavirus subgenus Sarbecovirus [1].
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128549/
COVID-19: Zoonotic aspects https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128549/
FAUCI: "not see any particular end in sight" https://www.advisory.com/daily-briefing/2020/07/23/coronavirus-update
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, on Wednesday said he does "not see any particular end in sight" to the coronavirus pandemic, as new cases, hospitalizations, and deaths related to the coronavirus continue to climb and strain hospitals throughout the United States.
Is it time to shut down—again? Some states should 'seriously' consider it, Fauci says.
US new coronavirus cases near 4M, deaths top 143K
U.S. officials as of Thursday morning had reported 3,980,100 total cases of the new coronavirus since the country's epidemic first began—up from 3,910,300 cases reported as of Wednesday morning.
50,000 NEW CASES: https://www.worldometers.info/coronavirus/
THE VIRUS IS ZOONOTIC AND WILL ALWAYS RESURFACE. COVID-19 IS A VERY AGGRESSIVELY MUTATING VIRUS. AND IT IS ADAPTING TO EVERYTHING WE ARE TRYING.
THE SPREAD WILL NEVER STOP. SOME POSTERS THINK THAT COVID-19 WILL STOP SPREADING OR BE ERADICATED. THIS IS IMPOSSIBLE. COVID-19 IS A ZOONOTIC VIRUS. AND THE FAMILY, “CORONAVIRIDAE” HAS THRIVED FOR DECADES. THE WORLD HEALTH ORGANIZATION, CENTERS FOR DISEASE CONTROL AND THE DEPARTMENT OF HEALTH AND HUMAN SERVICES KNEW ABOUT THIS FOR DECADES. COVID-19 IS OUT AND SPREADING RAPIDLY. THERE HAS NEVER BEEN SUCH INCREDIBLE AMOUNTS OF GOVERNMENT MONEY SPENT ON A SINGLE VIRUS OR CONTINGENCY MEASURES IMPLEMENTED FOR A SINGLE VIRUS IN HISTORY. THINK ABOUT THIS.
TOP PROFESSIONALS CALL FOR SHUT DOWN:
https://www.nbcnews.com/nightly-news/video/top-health-experts-call-for-u-s-to-shut-down-to-slow-coronavirus-spread-88291909764
SHUT IT DOWN:
REALLY NOW? One question still dogs Trump: Why not try harder to solve the coronavirus crisis?
https://www.washingtonpost.com/politics/trump-not-solve-coronavirus-crisis/2020/07/26/7fca9a92-cdb0-11ea-91f1-28aca4d833a0_story.html
In recent developments, a company named Decision Diagnostics has unveiled a brand new COVID-19 test, that hit the international markets with over twenty million units ordered in the first three days. The test comprises a technology that identifies the Corona virus by its resistance to an electrical charge that is directly applied to the test sample. The test furnishes diagnostic results as fast as 10.5 seconds and is already reducing the backlogs of the laboratories that have struggled to furnish test results for three weeks. The laboratories that are using the new test, called the Genviro, hailed it as a miracle breakthrough technology, unlike any other test they know about. Major pharmaceutical companies have made tender offers to buy the parent company and patents to the device. And the United States Government and Trump Administration has also implemented a special order of 100 million units for the armed forces and municipal bodies. Trump Stated that he never thought that a single test could change the face of medical diagnostics with such beneficial impact to the nation. Trump additionally stated that he was impressed with the technology and offered the company a $10 billion grant to develop additional tests for other viruses, to decrease diagnostic burdens on national laboratories to speed things up.